AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Hermab 150mg Injection

Prescription Icon
Prescription Required

Marketer

RPG Life Sciences Ltd

Salt Composition

Trastuzumab (150mg)

Overview Hermab 150mg Injection

Trastuzumab 150mg injection treats breast and gastric cancers by targeting and destroying HER2-positive cancer cells. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your individual needs and may vary. Strict adherence to your doctor's prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be immediately apparent, requiring weeks or months; discontinuation should only occur under medical supervision. Common side effects include nausea, headache, skin rash, sleep disturbances, and increased infection risk. This medication can suppress blood cell production, potentially increasing infection vulnerability, necessitating regular blood tests to monitor blood counts, heart function, liver health, and uric acid levels. Report any shortness of breath, cough, chills, or limb swelling to your doctor immediately. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout the treatment period.

Uses of Hermab 150mg Injection

Cancers affecting the breast and stomach.

Major Benefits of Hermab 150mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Hermab 150mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Hermab 150mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Hermab 150mg Injection works:

Hermab 150mg Injection, a genetically engineered IgG1 monoclonal antibody, targets HER2 receptors—proteins driving excessive growth in breast and gastric cancers. By blocking HER2 activity, it eliminates cancer cells and disrupts multiple downstream signaling pathways implicated in cancer development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Hermab 150mg Injection and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Hermab 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Hermab 150mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Hermab 150mg Injection's effect on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Hermab 150mg Injection appears safe for use in individuals with kidney impairment. Preliminary findings indicate dose modification may be unnecessary. Physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Hermab 150mg Injection to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Hermab 150mg Injection :

Omit a Hermab 150mg Injection dose? Seek your physician's advice.

Facts to Know About Hermab 150mg Injection

LabelValue
Chemical Type Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Medications
Action Class Monoclonal Antibody HER2/neu (ErbB2) Inhibitor

FAQs on Hermab 150mg Injection

Hermab 150mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, and unusual bleeding or bruising. Other possible side effects are stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea or vomiting, loss of appetite, rapid heartbeat, discolored or decreased urine output, painful urination, and other signs of infection. Contact your doctor immediately if you experience any of these symptoms.
Effective contraception is recommended for women of childbearing age throughout Hermab 150mg Injection therapy and for seven months afterward. Pregnancy planning can resume seven months post-treatment.
Treatment with Hermab 150mg Injection for early-stage breast cancer should last one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Hermab 150mg Injection does not require fasting before administration. It must be administered by a healthcare professional under the supervision of a physician experienced in cancer chemotherapy.
Hermab 150mg Injection is available in two formulations: intravenous (IV) infusion and subcutaneous (SC) injection. Always verify the correct formulation is used as prescribed, as the IV formulation is not for SC use. Your doctor may decide to change your treatment between the IV and SC formulations if clinically appropriate.
Hermab 150mg Injection, a monoclonal antibody, targets the HER2 protein found on some cancer cells. Because it works by binding to HER2 to inhibit cancer growth, it's only effective in patients with HER2-positive cancer and is not indicated for use in those with HER2-negative cancer.
Using Hermab 150mg Injection with anthracycline cancer drugs (like doxorubicin) can harm your heart. Therefore, your doctor must assess your heart health before and during treatment.
Cardiac evaluations should begin at treatment onset, continue every three months during treatment, and then every six months post-treatment for up to 24 months following the final Hermab 150mg Injection dose. Patients with pre-existing cardiac conditions require evaluations every 12 weeks.
Hermab 150mg Injection
16,005
MRP 19,500
17% off